Friday, December 13, 2024
HomeJan 15-31, 2024Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in patients with cardiovascular...

Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in patients with cardiovascular disease

A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial

Amber Sleem, Mark B. Effron, Amanda Stebbins,
Lisa M. Wruck, Guillaume Marquis-Gravel, et al

Abstract

Background: Clinicians recommend enteric-coated aspirin to decrease gastrointestinal bleeding in secondary prevention of coronary artery disease even though studies suggest platelet inhibition is decreased with enteric-coated vs uncoated aspirin formulations.
Objective: To assess whether receipt of enteric-coated vs uncoated aspirin is associated with effectiveness or safety outcomes.

Design, Setting, and Participants: This is a post hoc secondary analysis of ADAPTABLE (Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness), a pragmatic study of 15 076 patients with atherosclerotic cardiovascular disease having data in the National Patient-Centered Clinical Research Network. Patients were enrolled from April 19, 2016, through June 30, 2020, and randomly assigned to receive high (325 mg) vs low (81 mg) doses of daily aspirin. The present analysis assessed the effectiveness and safety of enteric-coated vs uncoated aspirin among those participants who reported aspirin formulation at baseline. Data were analyzed from November 11, 2019, to July 3, 2023.

Intervention: ADAPTABLE participants were regrouped according to aspirin formulation self-reported at baseline, with a median (IQR) follow-up of 26.2 (19.8-35.4) months.
Main Outcomes and Measures: The primary effectiveness end point was the cumulative incidence of the composite of myocardial infarction, stroke, or death from any cause, and the primary safety end point was major bleeding events (hospitalization for a bleeding event with use of a blood product or intracranial hemorrhage). Cumulative incidence at median follow-up for primary effectiveness and primary safety end points was compared between participants taking enteric-coated or uncoated aspirin using unadjusted and multivariable Cox proportional hazards models. All analyses were conducted for the intention-to-treat population.

Results: Baseline aspirin formulation used in ADAPTABLE was self-reported for 10 678 participants (median [IQR] age, 68.0 [61.3-73.7] years; 7285 men [68.2%]), of whom 7366 (69.0%) took enteric-coated aspirin and 3312 (31.0%) took uncoated aspirin. No significant difference in effectiveness (adjusted hazard ratio [AHR], 0.94; 95% CI, 0.80-1.09; P = .40) or safety (AHR, 0.82; 95% CI, 0.49-1.37; P = .46) outcomes between the enteric-coated aspirin and uncoated aspirin cohorts was found. Within enteric-coated aspirin and uncoated aspirin, aspirin dose had no association with effectiveness (enteric-coated aspirin AHR, 1.13; 95% CI, 0.88-1.45 and uncoated aspirin AHR, 0.99; 95% CI, 0.83-1.18; interaction P = .41) or safety (enteric-coated aspirin AHR, 2.37; 95% CI, 1.02-5.50 and uncoated aspirin AHR, 0.89; 95% CI, 0.49-1.64; interaction P = .07).

Conclusions and Relevance: In this post hoc secondary analysis of the ADAPTABLE randomized clinical trial, enteric-coated aspirin was not associated with significantly higher risk of myocardial infarction, stroke, or death or with lower bleeding risk compared with uncoated aspirin, regardless of dose, although a reduction in bleeding with enteric-coated aspirin cannot be excluded. More research is needed to confirm whether enteric-coated aspirin formulations or newer formulations will improve outcomes in this population.

Ref: JAMA Cardiol. Published online October 4, 2023. doi:10.1001/jamacardio.2023.3364

LEAVE A REPLY

Please enter your comment!
Please enter your name here

RELATED ARTICLES
- Advertisment -spot_imgspot_imgspot_imgspot_img

Most Popular

Recent Comments

Naheed Malik on Sons of the Soil!
Abid Ali Khan on Sons of the Soil!
Alaf Khan on LETTERS
Naheed Malik on Head Aches
Saira Bhatti on Head Aches
Abid Ali Khan on Head Aches
Muhammad Waseem Siddiqui on Prof. Zafarullah Chaudhry passes away
Naheed Malik on Being a Medical Doctor
Irfan Talib on Being a Medical Doctor
muhammad Irfan Talib on Being a Medical Doctor
Tariq Mufti on Know thy Body
Tariq Mufti on Social Media Disease
Imran Rashid on Life begins at eighty!
Saira Bhatti on Know thy Body
Abid Ali Khan on Social Media Disease
Prof Ghulam Asghar Channa on Functioning of the Basic Health Units
Abid Ali Khan on Biological Clock
Syed Abdullah on Dr. Azam Ali 1966 – 2024
Tariq Raheem on Dr. Azam Ali 1966 – 2024
Ahmed Badar on Prof. Khwaja Sadiq Husain
Munawar Aiz on LETTERS
Alaf khan on LETTERS
Nadeem Alam Zubairi on Thank You Prof. Zafarullah Chaudhry